Digestive & Intestinal Remedies (Pharmacies) - Kenya

  • Kenya
  • Revenue in the Digestives & Intestinal Remedies market is projected to reach US$23.40m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 1.40%, resulting in a market volume of US$25.09m by 2029.
  • In global comparison, most revenue will be generated in China (US$3,367.00m in 2024).
  • In relation to total population figures, per person revenues of US$0.42 are generated in 2024.

Key regions: Australia, United States, India, Europe, China

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Digestive & Intestinal Remedies (Pharmacies) market in Kenya is experiencing significant growth and development.

Customer preferences:
Customers in Kenya are increasingly seeking digestive and intestinal remedies from pharmacies. This can be attributed to various factors such as changing dietary habits, increased stress levels, and a growing awareness of the importance of digestive health. Customers are looking for effective and convenient solutions to common digestive issues such as indigestion, bloating, and constipation.

Trends in the market:
One of the key trends in the Digestive & Intestinal Remedies (Pharmacies) market in Kenya is the rising demand for natural and herbal remedies. Many customers are opting for natural products that are perceived to have fewer side effects and are more aligned with their preference for holistic health. This trend is in line with the global shift towards natural and organic products. Another trend in the market is the increasing availability and accessibility of digestive and intestinal remedies in pharmacies across Kenya. Pharmacies are expanding their product offerings to cater to the growing demand, and customers can now find a wide range of over-the-counter remedies for various digestive issues. This increased availability is making it easier for customers to access the products they need.

Local special circumstances:
Kenya has a diverse population with different dietary habits and lifestyles. This diversity creates a demand for a variety of digestive and intestinal remedies to address specific needs. For example, customers who consume a traditional Kenyan diet may require remedies that target specific digestive issues associated with their diet. Additionally, the high prevalence of gastrointestinal infections in Kenya due to poor sanitation and hygiene practices creates a need for remedies that can alleviate symptoms and promote gut health.

Underlying macroeconomic factors:
The growth of the Digestive & Intestinal Remedies (Pharmacies) market in Kenya can also be attributed to the country's overall economic development. As Kenya's economy continues to grow, there is an increase in disposable income, which allows customers to spend more on healthcare products. Additionally, the expansion of the middle class in Kenya is contributing to the growth of the market, as this segment of the population is more health-conscious and willing to invest in preventive healthcare. In conclusion, the Digestive & Intestinal Remedies (Pharmacies) market in Kenya is experiencing growth and development due to changing customer preferences, increasing availability of products, local special circumstances, and underlying macroeconomic factors. As customers become more aware of the importance of digestive health and seek convenient solutions, the market is expected to continue growing in the coming years.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)